XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2022
Summary of Significant Accounting Policies [Abstract]  
Schedule of credit and concentration risks
  Percentage of Sales 
Customer  June 30,
2022
   June 30,
2021
 
   (Unaudited)   (Unaudited) 
1   29.5%   41.3%
2   26.4%   20.8%
3   10.3%   
*
 
4   
**
    14.1%

 

  Percentage of Sales 
Customer  June 30,
2022
   June 30,
2021
 
   (Unaudited)   (Unaudited) 
1   28.4%   34.4%
2   25.8%   26.9%
3   13.7%   15.7%
4   10.0%   
*
 

 

   Percentage of Receivables 
Customer  June 30,
2022
   December 31,
2021
 
         
1   43.4%   50.3%
2   12.5%   12.7%
3   11.8%   11.7%

 

Schedule of revenue from contracts with customers
   Three Months Ended   Six Months Ended 
Product  June 30, 2022   June 30, 2021   June 30, 2022   June 30, 2021 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Military  $11,801,000   $13,332,000   $22,134,000   $25,835,000 
Commercial   2,207,000    2,121,000    3,936,000    3,330,000 
Total  $14,008,000   $15,453,000   $26,070,000   $29,165,000 

 

Schedule of net income (loss) applicable to common stockholders
   Three Months Ended   Six Months Ended 
   June 30,
2022
   June 30,
2021
   June 30,
2022
   June 30,
2021
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Net (Loss) Income - Basic  $(7,000)  $239,000   $(35,000)  $87,000 
Add: Convertible Note Interest for Potential Note Conversion   
-
    77,000    
-
    155,000 
                     
(Loss) Income used to calculate diluted earnings per share  $(7,000)  $316,000   $(35,000)  $242,000 

 

Schedule of basic and diluted earnings per share
   Three Months Ended   Six Months Ended 
   June 30,
2022
   June 30,
2021
   June 30,
2022
   June 30,
2021
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Weighted average shares outstanding used to compute basic earnings per share   32,213,769    32,021,522    32,212,853    31,996,859 
Effect of dilutive stock options and warrants   
-
    1,912,500    
-
    2,750,500 
Effect of dilutive convertible notes payable   
-
    4,057,892    
-
    4,057,892 
Weighted average shares outstanding and dilutive securities
used to compute dilutive earnings per share
 
 
 
 
 
32,213,769
 
 
 
 
 
 
 
37,991,914
 
 
 
 
 
 
 
32,212,853
 
 
 
 
 
 
 
38,805,251
 
 

 

Schedule of exercise price was greater than the average market price
   Three Months Ended   Six Months Ended 
   June 30,
2022
   June 30,
2021
   June 30,
2022
   June 30,
2021
 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Stock Options   2,364,332    456,000    2,364,332    98,000 
Warrants   760,000    1,903,000    760,000    1,423,000 
    3,124,332    2,359,000    3,124,332    1,521,000 

 

Schedule of anti-dilutive due to the net loss
   Three and Six Months Ended 
  

June 30,

2022

  

June 30,
2021

 
   (Unaudited)   (Unaudited) 
Convertible notes payable   4,058,000    
     -
 
    4,058,000    
-